Publications by authors named "John Mertens"

Claim this Profile
T
The impact of HF-rTMS treatment on serotonin(2A) receptors in unipolar melancholic depression.
Chris Baeken, Rudi De Raedt, Axel Bossuyt, Christian Van Hove, John Mertens

Brain Stimul· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.
Matthias Bauwens, Lena Wimana, Marleen Keyaerts, Cindy Peleman, Tony Lahoutte, John Mertens

Cancer Biother Radiopharm· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical quantum chemical and experimental study of the potentiality of direct labeling of the CN group with [(99m)Tc(CO)(3)](+) or [(186/188)Re(CO)(3)](+) in CN containing biomolecules.
Benasser Safi, John Mertens, Ken Kersemans, Paul Geerlings

Nucl Med Biol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Method for stabilizing non carrier added 2-[(18)F]fluoromethyl-l-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation.
Ken Kersemans, Matthias Bauwens, John Mertens

Nucl Med Biol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of [123I]-2-iodo-L-phenylalanine as an early radiotherapy evaluation tool: in vitro R1M rabdomyosarcoma cell and in vivo mouse experiments.
Veerle Kersemans, Valentijn Vergote, Virginie de Gelder, Indira Madani, Hubert Thierens, John Mertens

Cancer Biother Radiopharm· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine.
Matthias Bauwens, Marleen Keyaerts, Tony Lahoutte, Ken Kersemans, Vicky Caveliers, John Mertens

Nucl Med Commun· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
123I-2-iodo-tyrosine, a new tumour imaging agent: human biodistribution, dosimetry and initial clinical evaluation in glioma patients.
Marleen Keyaerts, Tony Lahoutte, Bart Neyns, Vicky Caveliers, Chris Vanhove, John Mertens

Eur J Nucl Med Mol Imaging· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D- and L-[123I]-2-I-phenylalanine show a long tumour retention compared with D- and L-[123I]-2-I-tyrosine in R1M rhabdomyosarcoma tumour-bearing Wag/Rij rats.
Matthias Bauwens, Tony Lahoutte, Ken Kersemans, Vicky Caveliers, Axel Bossuyt, John Mertens

Contrast Media Mol Imaging· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amino acids labeled with [99mTc(CO)3]+ and recognized by the L-type amino acid transporter LAT1.
Yu Liu, Jae Kyoung Pak, Paul Schmutz, Matthias Bauwens, John Mertens

J Am Chem Soc· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
Veerle Kersemans, Bart Cornelissen, Ken Kersemans, Matthias Bauwens, Rudi A Dierckx, John Mertens

Eur J Nucl Med Mol Imaging· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo.
Matthias Bauwens, Tony Lahoutte, Ken Kersemans, Carol Gallez, Axel Bossuyt, John Mertens

Nucl Med Biol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
Veerle Kersemans, Ken Kersemans, Bart Cornelissen, Ludovicus Staelens, Bart de Spiegeleer, John Mertens

Cancer Biother Radiopharm· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.
Veerle Kersemans, Bart Cornelissen, Ken Kersemans, Rudi A Dierckx, Bart De Spiegeleer, John Mertens

Nucl Med Biol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of sedation and data acquisition method on tracer uptake in animal models: [123I]-2-iodo-L-phenylalanine in pentobarbital-sedated tumor-bearing athymic mice.
Veerle Kersemans, Bart De Spiegeleer, John Mertens, Guido Slegers

Nucl Med Biol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
Veerle Kersemans, Bart Cornelissen, Klaus Bacher, Ken Kersemans, Hubert Thierens, John Mertens

J Nucl Med· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
Veerle Kersemans, Bart Cornelissen, Ken Kersemans, Matthias Bauwens, Erik Achten, John Mertens

J Nucl Med· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPECT and PET amino acid tracer influx via system L (h4F2hc-hLAT1) and its transstimulation.
Tony Lahoutte, Vicky Caveliers, Simone M R Camargo, Raffaella Franca, Tamara Ramadan, John Mertens

J Nucl Med· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150.
Kathelijne Peremans, Kurt Audenaert, Frank Coopman, Peter Blanckaert, Filip Jacobs, John Mertens

Eur J Nucl Med Mol Imaging· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain.
Tony Lahoutte, John Mertens, Vicky Caveliers, Philippe R Franken, Hendrik Everaert

J Nucl Med· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased 5-HT2a receptor binding in patients with anorexia nervosa.
Kurt Audenaert, Koen Van Laere, Filip Dumont, Miriam Vervaet, Ingeborg Goethals, John Mertens

J Nucl Med· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of aging on brain perfusion and serotonin-2A receptor binding in the normal canine brain measured with single photon emission tomography.
Kathelijne Peremans, Kurt Audenaert, Peter Blanckaert, Filip Jacobs, Frank Coopman, John Mertens

Prog Neuropsychopharmacol Biol Psychiatry· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased tumor uptake of 3-(123)I-Iodo-L-alpha-methyltyrosine after preloading with amino acids: an in vivo animal imaging study.
Tony Lahoutte, Vicky Caveliers, Philippe R Franken, Axel Bossuyt, John Mertens

J Nucl Med· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis